Key result
The authors defend their previous cost-effectiveness analysis of detecting and treating diabetic retinopathy against criticisms regarding the rehabilitation of visually disabled persons with diabetes.
Answers are grounded in this paper and cite their sources.
Authors respond to a critique regarding assumptions about visual rehabilitation in their cost-effectiveness analysis of diabetic retinopathy.
Letters1 December 1996Cost-Effectiveness of Detecting and Treating Diabetic RetinopathyJonathan C. Javitt, MD, MPH and Lloyd Paul Aiello, MD, PhDJonathan C. Javitt, MD, MPHGeorgetown University Medical Center, Washington, DC 20007.Joslin Diabetes Center, Boston, MA 02215.Search for more papers by this author and Lloyd Paul Aiello, MD, PhDGeorgetown University Medical Center, Washington, DC 20007.Joslin Diabetes Center, Boston, MA 02215.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-125-11-199612010-00020 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We appreciate Dr. Lambert's interest in our work. However, contrary to his assertion, neither of the issues he raises limits the application of our study results to decision making.Dr. Lambert challenges our assumption that persons with diabetes who lose their sight are as likely to be rehabilitated as visually disabled persons in the rest of the population. He suggests that loss of proprioception and touch sensation associated with diabetes might cause persons with diabetes to value their sight more highly than do those without the disease. Although he presents no data to support this proposition, we can ...REFERENCE1. Javitt JC, Aiello LP, Ferris FL, Canner JK, Chiang YP, Greenfield SR. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care. 1994; 17:909-17. Google Scholar Author, Article, and Disclosure InformationAuthors: Jonathan C. Javitt, MD, MPH; Lloyd Paul Aiello, MD, PhDAffiliations: Georgetown University Medical Center, Washington, DC 20007.Joslin Diabetes Center, Boston, MA 02215. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRisk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of ageOutcomes-Based Reimbursement Policies for Chronic Care Pathways 1 December 1996Volume 125, Issue 11Page: 939KeywordsBlindnessDecision makingDiabetic retinopathyEye diseasesHealth careQuality of lifeTouchVision ePublished: 15 August 2000 Issue Published: 1 December 1996 Copyright & PermissionsCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Jonathan C. Javitt (1996) conducted a letter in Diabetic Retinopathy. Detecting and treating diabetic retinopathy was evaluated. The authors defend their previous cost-effectiveness analysis of detecting and treating diabetic retinopathy against criticisms regarding the rehabilitation of visually disabled persons with diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: